Annual Non Current Assets
$7.70 M
+$2.81 M+57.55%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual long term assets is $7.70 million, with the most recent change of +$2.81 million (+57.55%) on December 1, 2023.
- During the last 3 years, CYTO annual non current assets has fallen by -$2.81 million (-26.69%).
- CYTO annual non current assets is now -53.30% below its all-time high of $16.50 million, reached on December 31, 2021.
Performance
CYTO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$7.55 M
+$7.42 M+6104.93%
June 1, 2024
Summary
- As of February 8, 2025, CYTO quarterly long term assets is $7.55 million, with the most recent change of +$7.42 million (+6104.93%) on June 1, 2024.
- Over the past year, CYTO quarterly non current assets has increased by +$2.57 million (+51.64%).
- CYTO quarterly non current assets is now -56.50% below its all-time high of $17.34 million, reached on June 30, 2022.
Performance
CYTO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CYTO Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.5% | +51.6% |
| 3 y3 years | -26.7% | +54.3% |
| 5 y5 years | +99.0% | +54.3% |
CYTO Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.3% | +57.5% | -56.5% | +6104.9% |
| 5 y | 5-year | -53.3% | +57.5% | -56.5% | +6104.9% |
| alltime | all time | -53.3% | +1915.8% | -56.5% | +6104.9% |
Altamira Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $7.55 M(+6104.9%) |
| Dec 2023 | $1.46 M(-23.7%) | $121.60 K(-97.6%) |
| Jun 2023 | - | $4.98 M(+1.7%) |
| Dec 2022 | $1.91 M(-57.4%) | $4.89 M(-71.8%) |
| Jun 2022 | - | $17.34 M(+5.1%) |
| Dec 2021 | $4.48 M(-66.3%) | $16.50 M(+4.1%) |
| Jun 2021 | - | $15.84 M(+50.7%) |
| Dec 2020 | $13.30 M(+442.7%) | $10.51 M(+32.0%) |
| Jun 2020 | - | $7.96 M(+12.6%) |
| Dec 2019 | $2.45 M(-60.2%) | $7.07 M(+27.6%) |
| Jun 2019 | - | $5.54 M(+43.2%) |
| Dec 2018 | $6.16 M(-62.2%) | $3.87 M(+92.2%) |
| Sep 2018 | - | $2.01 M(-8.6%) |
| Jun 2018 | - | $2.20 M(+8.6%) |
| Mar 2018 | - | $2.03 M(+0.9%) |
| Dec 2017 | $16.29 M | $2.01 M(-1.0%) |
| Sep 2017 | - | $2.03 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $2.03 M(+3.0%) |
| Mar 2017 | - | $1.97 M(+2.0%) |
| Dec 2016 | $33.11 M(-35.9%) | $1.93 M(+6.0%) |
| Sep 2016 | - | $1.82 M(+4.6%) |
| Jun 2016 | - | $1.74 M(-2.2%) |
| Mar 2016 | - | $1.78 M(+1.0%) |
| Dec 2015 | $51.67 M(-11.5%) | $1.76 M(-1.0%) |
| Sep 2015 | - | $1.78 M(-4.5%) |
| Jun 2015 | - | $1.86 M(+6.3%) |
| Mar 2015 | - | $1.75 M(-1.0%) |
| Dec 2014 | $58.39 M(+110.9%) | $1.77 M(-2.5%) |
| Sep 2014 | - | $1.82 M(-6.6%) |
| Jun 2014 | - | $1.95 M(-1.0%) |
| Mar 2014 | - | $1.97 M(+3.9%) |
| Dec 2013 | $27.69 M(+6486.5%) | $1.89 M |
| Dec 2012 | $420.40 K(-60.6%) | - |
| Dec 2011 | $1.07 M | - |
FAQ
- What is Altamira Therapeutics annual long term assets?
- What is the all time high annual non current assets for Altamira Therapeutics?
- What is Altamira Therapeutics annual non current assets year-on-year change?
- What is Altamira Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly non current assets year-on-year change?
What is Altamira Therapeutics annual long term assets?
The current annual non current assets of CYTO is $7.70 M
What is the all time high annual non current assets for Altamira Therapeutics?
Altamira Therapeutics all-time high annual long term assets is $16.50 M
What is Altamira Therapeutics annual non current assets year-on-year change?
Over the past year, CYTO annual long term assets has changed by +$2.81 M (+57.55%)
What is Altamira Therapeutics quarterly long term assets?
The current quarterly non current assets of CYTO is $7.55 M
What is the all time high quarterly non current assets for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly long term assets is $17.34 M
What is Altamira Therapeutics quarterly non current assets year-on-year change?
Over the past year, CYTO quarterly long term assets has changed by +$2.57 M (+51.64%)